Rheumatology Highlights Monograph
Release Date: June 10, 2009
Expiration Date: June 10, 2010
 |
||
|
How to Obtain AMA PRA
|
|
 |
||
Estimated Time of Completion: 1 hour 45 minutes
Description
The Cleveland Clinic presents Rheumatology Highlights, a series of key scientific presentations from annual rheumatology meetings in 2008. Clinical experts attended these meetings and selected the most significant highlights of the scientific and clinic sessions/abstracts.
Objectives
After completing this learning activity, the participant will be able to:
- Summarize results from the most recently published biologic studies and clinical trials and assess their impact on clinical practice.
- Review the data addressing the use of nonbiologic DMARD therapy in RA treatment models.
- List the most important advances in basic science and describe how they affect current knowledge of genetic models.
- Discuss the newest research as it relates to the impact of rheumatoid arthritis on cardiovascular disease.
- Describe the association of lupus erythematosus on renal and cardiovascular disease as well as vitamin D levels.
- Evaluate the data regarding the safety and efficacy of biologic use in specific patient populations.
Target Audience
Rheumatologists and other health care professionals managing patients with rheumatologic diseases.
Accreditation
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 1.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.
Activity Director
Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of
Case Western Reserve University
Vice Chairman, Department of Rheumatic &
Immunologic Diseases
R.J. Fasenmyer Chair of Clinical Immunology
Orthopaedic & Rheumatologic Institute
Cleveland Clinic
Cleveland, OH
| Marc D. Cohen, MD Professor of Medicine National Jewish Health Denver, CO |
Daniel E. Furst, MD Carl M. Pearson Professor of Medicine David Geffen School of Medicine University of California Los Angeles Los Angeles, CA |
Allan Gibofsky, MD Professor of Medicine and Public Health Weill Medical College of Cornell University New York, NY |
| Elaine Husni, MD, MPH Assistant Professor, Lerner College of Medicine Director, Clinical Outcomes Research Director, Arthritis and Musculoskeletal Treatment Center Department of Rheumatic & Immunologic Diseases Orthopedic & Rheumatologic Institute Cleveland Clinic Cleveland, OH |
Susan M. Manzi, MD, MPH Associate Professor of Medicine and Epidemiology Director, Lupus Center of Excellence Schools of Health Sciences University of Pittsburgh Pittsburgh, PA |
Faculty Disclosure
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they may have a relationship that, in the context of their presentation, could be perceived as a potential conflict of interest:
| Leonard Calabrese, DO | ||
| Consulting: | Elan; Roche | |
| Consulting, Teaching and Speaking: | Abbott; Amgen; Genentech; Wyeth | |
| Marc Cohen, MD | ||
| Consulting: | Abbott; Amgen; Genentech; UCB; Wyeth | |
| Employment: | Centocor | |
| Allan Gibofsky, MD | ||
| Advisory Board: | UCB | |
| Consulting, Ownership Interest, Teaching and Speaking: | Abbott; Amgen/Wyeth; BMS | |
| Ownership Interest, Teaching and Speaking: | Pfizer | |
| Teaching and Speaking: | Roche | |
| Susan Manzi, MD, MPH | ||
| Advisory Committee/Review Panel: | Abbott Scholar Program; Centocor; FDA - Arthritis Advisory Board; Genzyme; La Jolla Pharmaceutical Company | |
| Advisory Committee/Review Panel, Research: | Aspreva-Asia Pacific; Bristol-Myers Squibb; Genelabs; Human Genome Sciences | |
| Advisory Committee/Review Panel, Consulting, Research: | Genentech | |
| Consultant: | Cellotape Corporation; StageMark, Inc. | |
| Research: | Amgen; Immunomedics | |
The following faculty have indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest:
Daniel Furst, MD
Elaine Husni, MD, MPH
The Cleveland Clinic Foundation Center for Continuing Education acknowledges an educational grant for support of this activity from:
Bristol-Myers Squibb
This CME activity was produced by The Cleveland Clinic Foundation Center for Continuing Education and UNITECH Communications®.
